possible link between atypical antipsychotics and diabetes

You'll see more attention on the possible link between atypical antipsychotics and diabetes.

The FDA and drug companies will battle out new label warnings about an increased risk of diabetes for patients on atypicals.

The FDA wants the warnings to apply to ALL atypicals. But some companies don't think the warning applies to their drug.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote